Corbus Pharmaceuticals Holdings (CRBP) Preferred Stock Liabilities (2013)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Preferred Stock Liabilities of $1.1 million in Q4 2013.

Corbus Pharmaceuticals Holdings (CRBP) Preferred Stock Liabilities (2013) Analysis & Trends

Corbus Pharmaceuticals Holdings' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $1.1 million for Q4 2013.

  • In Q4 2013, Preferred Stock Liabilities changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2013 stood at $1.1 million (changed N/A YoY), while the FY2013 annual figure was $1.1 million, changed N/A from the prior year.
  • Preferred Stock Liabilities was $1.1 million for Q4 2013 at Corbus Pharmaceuticals Holdings.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $1.1 million in Q4 2013 to a low of $1.1 million in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 Corbus Pharmaceuticals Holdings 136.49 Mn 108.68 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 1.11 Mn